The Choice of Protamine Sulfate Dosing Regimen for Coronary Artery Bypass Graft Surgery

Andriy P. Mazur; Artur V. Gabriyelyan; Pavlo V. Hurin; Maksim M. Babich; Vladyslav V. Antonenko; Vladyslav S. Shevelukha

doi:10.30702/ujcvs/22.30(02)/MG017-2226

Andriy P. Mazur National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine https://orcid.org/0000-0002-6873-7573
Artur V. Gabriyelyan Shalimov’s National institute of Surgery and Transplantation, Kyiv, Ukraine https://orcid.org/0000-0002-4141-5902
Pavlo V. Hurin Shalimov’s National institute of Surgery and Transplantation, Kyiv, Ukraine https://orcid.org/0000-0002-2234-1258
Maksim M. Babich Shalimov’s National institute of Surgery and Transplantation, Kyiv, Ukraine https://orcid.org/0000-0002-7272-8688
Vladyslav V. Antonenko Shalimov’s National institute of Surgery and Transplantation, Kyiv, Ukraine https://orcid.org/0000-0003-2395-4563
Vladyslav S. Shevelukha Shalimov’s National institute of Surgery and Transplantation, Kyiv, Ukraine https://orcid.org/0000-0002-9520-9290

DOI: https://doi.org/10.30702/ujcvs/22.30(02)/MG017-2226

Keywords: heparin, protamine, hemodynamics, perioperative blood loss, blood transfusion, hemostasis

Abstract

Changes in hemodynamics and coagulation hemostasis during the use of protamine sulfate to neutralize heparin in a ratio of 0.5:1 in coronary artery bypass graft surgery have been studied. A comparative analysis of hemodynamic abnormalities, postoperative blood loss, and the need for blood transfusion in patients receiving protamine sulfate at the above dose has been carried out. The study included 70 patients who were successively operated on at the Shalimov National Institute of Surgery and Transplantation due to coronary heart disease, in whom coronary artery bypass grafting was performed on a working heart. The study group included 30 patients in whom heparin was neutralized with protamine in a ratio of 1:0.5. The comparison group included patients in whom heparin was neutralized with protamine in a ratio of 1:1. Statistical processing of the material was performed using the software StatPlus professional 2007. Both parametric and non-parametric methods of statistical analysis were used. The parametric method (Student’s t-test) was used to test the hypothesis of the equality of the mean values of two samples from different general sets. Pearson’s criterion was used to compare the two sets by qualitative features. Statistically significant differences in the obtained results were considered at p <0.05, which indicated a 95% probability of discrepancies. Changes in blood pressure, central venous pressure, electrocardiogram, cardiac output, cardiac index, coagulogram, complete blood count, biochemical blood test, electrolyte, acid-base and gas composition of blood during surgery and in the postoperative period were analyzed. The results showed that reduction in the dose of protamine to neutralize heparin is effective and safe in patients undergoing coronary artery bypass grafting. However, changes in hemodynamics and coagulogram in patients treated with 50% protamine dose were insignificant and did not increase perioperative blood loss and blood transfusion needs.

References

1. MurugeshWR,PrasadSS,RamachandrappaSujayK,Dinesh Kumar US. Is a fixed low-dose protamine better at reducing postoperative bleeding in off pump coronary artery bypass grafting? Asian Cardiovasc Thorac Ann. 2021;29(9):922-7. https://doi.org/10.1177/0218492321997393

2. Lee MH, Riley W, Shann KG. Can the Minimum Protamine Dose to Neutralize Heparin at the Completion of Cardiopulmonary Bypass be Significantly Lower than the Conventional Practice? J Extra Corpor Technol. 2021 Sep;53(3):170-176. https://doi.org/10.1182/ject-2100023

3. Chakravarthy M, Prabhakumar D, Thimmannagowda P, Krishnamoorthy J, George A, Jawali V. Comparison of two doses of heparin on outcome in off-pump coronary artery bypass surgery patients: A prospective randomized control study. Ann Card Anaesth. 2017;20(1):8-13. https://doi.org/10.4103/0971-9784.197818

4. Welsby IJ, Newman MF, Phillips-Bute B, Messier RH, Kakkis ED, Stafford-Smith M. Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery. Anesthesiology. 2005;102(2):308-14. https://doi.org/10.1097/00000542-200502000-00011

5. Bull BS, Huse WM, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69(5):685-9. PMID: 1127967.

6. Griffin MJ, Rinder HM, Smith BR, Tracey JB, Kriz NS, Li CK, et al. The effects of heparin, protamine, and heparin/ protamine reversal on platelet function under conditions of arterial shear stress. Anesth Analg. 2001;93(1):20-7. https://doi.org/10.1097/00000539-200107000-00005

7. DeLaria GA, Tyner JJ, Hayes CL, Armstrong BW. Heparin-protamine mismatch. A controllable factor in bleeding after open heart surgery. Arch Surg. 1994;129(9):944-50. https://doi.org/10.1001/archsurg.1994.01420330059012

8. De Simone F, Nardelli P, Licheri M, Frau G, Redaelli MB, Monaco F, et al. Less is more: We are administering too much protamine in cardiac surgery. Ann Card Anaesth. 2021;24(2):178-82. https://doi.org/10.4103/aca.ACA_26_19

9. National Institute for Health and Care Excellence. Blood transfusion. NICE guidline [Internet]. 2015 Nov 18 [updated 2022 March; cited 2022 Apr 2]. Available from: www.nice.org.uk/guidance/ng24

The Choice of Protamine Sulfate Dosing Regimen for Coronary Artery Bypass Graft Surgery

Abstract

References

Most read articles by the same author(s)